Bio Essence

Bio Essence Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of Bio Essence (BIOE) as of Oct 16, 2026 is 175.16 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was -47.67 % — a change of -467.46% (higher).

Cash Conversion

175.16 %

YoY

-467.46%

Last updated:

Cash Conversion Rate (OCF/Net Income) of Bio Essence is 2025 175.16 % . Cash Conversion Rate (OCF/Net Income) of Bio Essence was 2024 -47.67 % . It decreases by -467.46% higher compared to the previous year.

The Bio Essence Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2018
56.97 USD
Jan 1, 2019
52.65 USD
Jan 1, 2020
122.98 USD
Jan 1, 2021
199.84 USD
Jan 1, 2022
86.85 USD
Jan 1, 2023
105.53 USD
Jan 1, 2024
-47.67 USD
Jan 1, 2025
175.16 USD
The Bio Essence Cash Conversion history
YEARCash ConversionYoY
175.16 %-467.46%
-47.67 %-145.17%
105.53 %+21.51%
86.85 %-56.54%
199.84 %+62.51%
122.98 %+133.55%
52.65 %-7.57%
56.97 %-52.36%
119.59 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bio Essence Stock analysis

What does Bio Essence do? Bio Essence Corp, trading under the ticker BIOE with ISIN US09090C1053, is a U.S.-based company headquartered in Irvine, California. The company made its initial public offering on March 30, 2022. Bio Essence Corp operates through three subsidiaries: Bio Essence Pharmaceutical, Inc. (BEP), Bio Essence Herbal Essentials Inc. (BEH), and McBE Pharma, Inc. (McBE). BEP functions as an original equipment manufacturer (OEM) for health supplements. BEH serves the practitioners' market with herbal products available in granules, capsules, pills, and tablets, and offers special formulation services to healthcare practitioners. McBE focuses on the development, manufacturing, and sales of prescription drugs. The company provides nutritional supplements, including herbal, diet, and vitamin products, and facilitates direct connections between customers and integrative healthcare practitioners such as dietitians and nutraceutical practitioners. Bio Essence Corp does not specify its sector or industry in the provided information. The company’s business model emphasizes integrated health supplements and research-intensive products, though the nature of its research activities is not detailed. It operates without a publicly disclosed founding year, and no acquisitions or specific product names beyond the subsidiaries are mentioned. The company's operations are centered around its subsidiaries' distinct roles in the health supplement and pharmaceutical markets. Bio Essence is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio Essence stock

Cash Conversion Rate (OCF/Net Income) of Bio Essence is 175.16 % in 2025.

Cash Conversion Rate (OCF/Net Income) of Bio Essence changed from -47.67 % to 175.16 %, representing a -467.46% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) Bio Essence since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s Bio Essence with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Bio Essence

All Key Metrics — Bio Essence